These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1620 related articles for article (PubMed ID: 34976920)

  • 61. Long-term Effects of the COVID-19 Pandemic on Public Sentiments in Mainland China: Sentiment Analysis of Social Media Posts.
    Tan H; Peng SL; Zhu CP; You Z; Miao MC; Kuai SG
    J Med Internet Res; 2021 Aug; 23(8):e29150. PubMed ID: 34280118
    [TBL] [Abstract][Full Text] [Related]  

  • 62. China's practice to prevent and control COVID-19 in the context of large population movement.
    Xu TL; Ao MY; Zhou X; Zhu WF; Nie HY; Fang JH; Sun X; Zheng B; Chen XF
    Infect Dis Poverty; 2020 Aug; 9(1):115. PubMed ID: 32814591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pacing Forward in the Face of Fragility: Lessons From African Institutions and Governments' Response to Public Health Emergencies.
    Bitanihirwe B; Ssewanyana D; Ddumba-Nyanzi I
    Front Public Health; 2021; 9():714812. PubMed ID: 34900886
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analyzing the Characteristics of Policies and Political Institutions for the Prevention and Control Governance of the COVID-19 Pandemic: Evidence from China.
    Dong M; Zhou C; Zhang Z
    Int J Environ Res Public Health; 2022 Sep; 19(17):. PubMed ID: 36078703
    [TBL] [Abstract][Full Text] [Related]  

  • 65. From SARS to Avian Influenza: The Role of International Factors in China's Approach to Infectious Disease Control.
    Goldizen FC
    Ann Glob Health; 2016; 82(1):180-8. PubMed ID: 27325075
    [TBL] [Abstract][Full Text] [Related]  

  • 66. COVID-19 Containment: Comparisons and Suggestions for Global Response.
    Cheng S; Zhao Y; Kaminga AC; Wang X; Zhang X; Xu H
    Inquiry; 2022; 59():469580221086142. PubMed ID: 35584986
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of China's Hubei control strategy for COVID-19 epidemic: an observational study.
    Liu Y; Zheng F; Du Z; Li J; Gu J; Jiang M; Yoneoka D; Gilmour S; Hao Y
    BMC Infect Dis; 2021 Aug; 21(1):820. PubMed ID: 34399697
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Challenges to the system of reserve medical supplies for public health emergencies: reflections on the outbreak of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic in China.
    Wang X; Zhang X; He J
    Biosci Trends; 2020 Mar; 14(1):3-8. PubMed ID: 32062645
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mediating Role of Intra-Team Conflict between Paternalistic Leadership and Decision-Making Quality among China University's CMT during COVID-19.
    Cheah KSL; Abdullah Z; Xiao M
    Int J Environ Res Public Health; 2022 Sep; 19(18):. PubMed ID: 36141967
    [TBL] [Abstract][Full Text] [Related]  

  • 70. The spatial transmission of SARS-CoV-2 in China under the prevention and control measures at the early outbreak.
    Liu J; Zhou Y; Ye C; Zhang G; Zhang F; Song C
    Arch Public Health; 2021 Jan; 79(1):8. PubMed ID: 33441168
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Chinese model in global COVID-19 prevention and control: Successful experience, institutional advantages and optimal path.
    Han Y; Xu T
    Heliyon; 2024 Feb; 10(3):e25701. PubMed ID: 38352781
    [TBL] [Abstract][Full Text] [Related]  

  • 72. "A community system": A critical foundation for the epidemic prevention and control of SARS-CoV-2.
    Zhang X; Yang S
    Int J Health Plann Manage; 2020 Sep; 35(5):1246-1249. PubMed ID: 32677114
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Impact of the COVID-19 Pandemic on China's Manufacturing Sector: A Global Value Chain Perspective.
    Song Y; Hao X; Hu Y; Lu Z
    Front Public Health; 2021; 9():683821. PubMed ID: 34055731
    [TBL] [Abstract][Full Text] [Related]  

  • 74. COVID-19 pandemic, government responses, and public mental health: Investigating consequences through crisis hotline calls in two countries.
    Arendt F; Markiewitz A; Mestas M; Scherr S
    Soc Sci Med; 2020 Nov; 265():113532. PubMed ID: 33223385
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Discussion on China's anti-epidemic response based on the Protocol on Prevention and Control of Coronavirus Disease 2019 from Chinese Authority.
    Zhao Z; Zhou Y; Li W; Fan X; Huang Q; Tang Z; Li H; Wang J; Li J; Wu J
    Int J Health Plann Manage; 2022 May; 37(3):1205-1220. PubMed ID: 35064592
    [TBL] [Abstract][Full Text] [Related]  

  • 76. COVID-19 Is a Crisis in Planetary Health and Politics of Expertise: Time to Think Critically and Innovate Both.
    Boschele M
    OMICS; 2021 May; 25(5):279-284. PubMed ID: 33961517
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Social Policy Responses to the Covid-19 Crisis in China in 2020.
    Lu Q; Cai Z; Chen B; Liu T
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32823833
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Status and Challenges of Public Health Emergency Management in China Related to COVID-19.
    Cao Y; Shan J; Gong Z; Kuang J; Gao Y
    Front Public Health; 2020; 8():250. PubMed ID: 32574311
    [No Abstract]   [Full Text] [Related]  

  • 79. Privacy lost: Appropriating surveillance technology in China's fight against COVID-19.
    Liu J; Zhao H
    Bus Horiz; 2021; 64(6):743-756. PubMed ID: 34629478
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Understanding China's growing involvement in global health and managing processes of change.
    Husain L; Bloom G
    Global Health; 2020 May; 16(1):39. PubMed ID: 32357894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 81.